These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2899932)

  • 41. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
    Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
    J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The fate of saccharin impurities: the excretion and metabolism of [3-14C]Benz[d]-isothiazoline-1,1-dioxide (BIT) in man and rat.
    Renwick AG; Williams RT
    Xenobiotica; 1978 Aug; 8(8):475-86. PubMed ID: 695691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disposition of nafimidone in rats.
    Graham DJ; Hama KM; Smith SA; Kurz L; Chaplin MD; Hall DJ
    Drug Metab Dispos; 1987; 15(4):565-70. PubMed ID: 2888632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of the clinical pharmacokinetics and metabolism of the alpha 1-adrenoceptor antagonist indoramin.
    Pierce DM
    Xenobiotica; 1990 Dec; 20(12):1357-67. PubMed ID: 1981634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution and metabolism of 1,2,4-trimethylbenzene (pseudocumene) in the rat.
    Huo JZ; Aldous S; Campbell K; Davies N
    Xenobiotica; 1989 Feb; 19(2):161-70. PubMed ID: 2728490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of the antimicrobial agent nibroxane, 5-bromo-2-methyl-5-nitro-m-dioxane, in the rat.
    Sullivan HR; Marshall FJ; Bopp RJ
    Xenobiotica; 1978 Aug; 8(8):495-502. PubMed ID: 695693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The metabolism of 14C-cyclohexylamine in mice and two strains of rat.
    Roberts A; Renwick AG
    Xenobiotica; 1985 Jun; 15(6):477-83. PubMed ID: 4036172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The metabolism and fate of closantel (Flukiver) in sheep and cattle.
    Michiels M; Meuldermans W; Heykants J
    Drug Metab Rev; 1987; 18(2-3):235-51. PubMed ID: 3330516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative autoradiographic localization of alpha 2-antagonist binding sites in rat brain using [3H]idazoxan.
    Brüning G; Kaulen P; Baumgarten HG
    Neurosci Lett; 1987 Dec; 83(3):333-7. PubMed ID: 2894626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pharmacokinetic-pharmacodynamic linking model for the alpha 2-adrenergic antagonism of idazoxan on clonidine-induced mydriasis in the rat.
    Valles J; Obach R; Menargues A; Pruñonosa J; Jane F
    J Pharm Pharmacol; 1995 Feb; 47(2):157-61. PubMed ID: 7602472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postischemic administration of idazoxan, an alpha-2 adrenergic receptor antagonist, decreases neuronal damage in the rat brain.
    Gustafson I; Miyauchi Y; Wieloch TW
    J Cereb Blood Flow Metab; 1989 Apr; 9(2):171-4. PubMed ID: 2564004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of flumecinol in humans.
    Klebovich I; Vereczkey L; Tóth E; Tamás J; Mák M; Jalsovszky G; Holly S
    Xenobiotica; 1987 Oct; 17(10):1247-58. PubMed ID: 3424871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics after intravenous and oral administration in man of the alpha 2-adrenoreceptor antagonist idazoxan (RX781094).
    Muir NC; Lloyd-Jones JG; Nichols JD; Clifford JM
    Eur J Clin Pharmacol; 1986; 29(6):743-5. PubMed ID: 2872058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The fate of saccharin impurities: the excretion and metabolism of toluene-2-sulphonamide in man and rat.
    Renwick AG; Ball LM; Corina DL; Williams RT
    Xenobiotica; 1978 Aug; 8(8):461-74. PubMed ID: 695690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The fate of saccharin impurities: the metabolism and excretion of 3-amino [3-14C]benz[d]-isothiazole-1,1-dioxide and 5-chlorosaccharin in the rat.
    Renwick AG
    Xenobiotica; 1978 Aug; 8(8):487-94. PubMed ID: 695692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of cysteine ethyl ester in rat.
    Servin AL; Goulinet S; Renault H
    Xenobiotica; 1988 Jul; 18(7):839-47. PubMed ID: 3176522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.